Canopy Growth Corp Payments for (Proceeds from) Other Investing Activities
Canopy Growth Corp (CGC) reported Payments for (Proceeds from) Other Investing Activities of -CAD 6.98 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2026-06-15
- Canopy Growth Corp payments for (proceeds from) other investing activities for the quarter ending 2026-03-31 was 0.00 CAD.
- Canopy Growth Corp payments for (proceeds from) other investing activities for the quarter ending 2025-12-31 was -6.40M CAD.
- Canopy Growth Corp payments for (proceeds from) other investing activities for the quarter ending 2025-03-31 was 0.00 CAD.
- Canopy Growth Corp payments for (proceeds from) other investing activities for the quarter ending 2024-12-31 was 0.00 CAD.
- Canopy Growth Corp payments for (proceeds from) other investing activities for fiscal 2026 was -6.98M CAD.
- Canopy Growth Corp payments for (proceeds from) other investing activities for fiscal 2025 was 0.00 CAD, a 100.00% decline from fiscal 2024.
- Canopy Growth Corp payments for (proceeds from) other investing activities for fiscal 2024 was 7.71M CAD.
- Canopy Growth Corp payments for (proceeds from) other investing activities for fiscal 2023 was -3.90M CAD, a 121.52% decline from fiscal 2022.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 3 month as first filed | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 6 month as first filed | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 9 month as first filed | Payments for (Proceeds from) Other Investing Activities 12 month | Payments for (Proceeds from) Other Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 0.00 CAD derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | -6.40M CAD derived: sum of 2 quarters · filed 2026-06-15 | -6.98M CAD 10-K · filed 2026-06-15 | |||||
| 2025-12-31 | -6.40M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | -6.98M CAD 10-Q · filed 2026-02-06 | ||||||
| 2025-09-30 | -581.00K CAD 10-Q · filed 2025-11-07 | |||||||
| 2025-03-31 | 0.00 CAD derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | 0.00 CAD derived: sum of 2 quarters · filed 2026-06-15 | 0.00 CAD 10-K · filed 2026-06-15 | |||||
| 2024-12-31 | 0.00 CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | 0.00 CAD 10-Q · filed 2026-02-06 | ||||||
| 2024-09-30 | 0.00 CAD 10-Q · filed 2025-11-07 | |||||||
| 2024-03-31 | -2.81M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | -2.81M CAD derived: sum of 2 quarters · filed 2026-06-15 | -2.85M CAD derived: sum of 3 quarters · filed 2026-06-15 | 7.71M CAD 10-K · filed 2026-06-15 | ||||
| 2023-12-31 | 0.00 CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | -43.00K CAD derived: sum of 2 quarters · filed 2025-02-07 | 10.51M CAD 10-Q · filed 2025-02-07 | 9.23M CAD 10-Q · filed 2024-02-09 | 8.66M CAD derived: sum of 4 quarters · filed 2025-05-30 | |||
| 2023-09-30 | -43.00K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | 10.51M CAD 10-Q · filed 2024-11-08 | 9.68M CAD 10-Q · filed 2023-11-09 | 8.66M CAD derived: sum of 3 quarters · filed 2025-05-30 | 13.76M CAD derived: sum of 4 quarters · filed 2025-05-30 | |||
| 2023-06-30 | 10.56M CAD 10-Q · filed 2024-08-09 | 10.19M CAD 10-Q · filed 2023-08-09 | 8.71M CAD derived: sum of 2 quarters · filed 2025-05-30 | 13.80M CAD derived: sum of 3 quarters · filed 2025-05-30 | ||||
| 2023-03-31 | -1.85M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | 3.24M CAD derived: sum of 2 quarters · filed 2025-05-30 | -3.90M CAD 10-K · filed 2025-05-30 | -4.18M CAD 10-K · filed 2023-06-22 | ||||
| 2022-12-31 | 5.09M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-09 | -2.05M CAD 10-Q · filed 2024-02-09 | -2.33M CAD 10-Q · filed 2023-02-09 | |||||
| 2022-09-30 | -7.14M CAD 10-Q · filed 2023-11-09 | |||||||
| 2022-03-31 | 1.37M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-30 | 7.27M CAD derived: sum of 2 quarters · filed 2024-05-30 | 9.76M CAD derived: sum of 3 quarters · filed 2024-05-30 | 18.13M CAD 10-K · filed 2024-05-30 | ||||
| 2021-12-31 | 5.90M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | 8.39M CAD derived: sum of 2 quarters · filed 2023-02-09 | 16.76M CAD 10-Q · filed 2023-02-09 | 18.51M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-09-30 | 2.49M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | 10.86M CAD 10-Q · filed 2022-11-09 | 12.61M CAD derived: sum of 3 quarters · filed 2023-06-22 | 21.36M CAD derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-06-30 | 8.37M CAD 10-Q · filed 2022-08-09 | 10.12M CAD derived: sum of 2 quarters · filed 2023-06-22 | 18.87M CAD derived: sum of 3 quarters · filed 2023-06-22 | |||||
| 2021-03-31 | 1.75M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 10.50M CAD derived: sum of 2 quarters · filed 2023-06-22 | 7.02M CAD 10-K · filed 2023-06-22 | |||||
| 2020-12-31 | 8.75M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | 5.27M CAD 10-Q · filed 2022-02-09 | ||||||
| 2020-09-30 | -3.48M CAD 10-Q · filed 2021-11-08 | |||||||
| 2020-03-31 | 24.48M CAD 10-K · filed 2022-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |